Profiling the emergence of phenotypic heterogeneity in breast cancer organoids
Cell-to-cell heterogeneity in biological systems has been broadly studied in unicellular organisms and mammals. Furthermore, non-genetic, in addition to genetic heterogeneity has been recently proposed to support tumour growth and...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
COLGENES
Defining novel mechanisms critical for colorectal tumourigen...
1M€
Cerrado
CLONCELLBREAST
CLONAL AND CELLULAR HETEROGENEITY OF BREAST CANCER AND ITS D...
2M€
Cerrado
BRCANCER
A novel approach for modeling development of breast cancer
208K€
Cerrado
MaCaROM
Mapping Cancer Response using Organoids and Mass cytometry
191K€
Cerrado
TrackingTumorStates
Tracking and Targeting Tumor States at single cell resolutio...
3M€
Cerrado
Información proyecto SpatialOrganoids
Duración del proyecto: 32 meses
Fecha Inicio: 2020-04-15
Fecha Fin: 2022-12-31
Líder del proyecto
UNIVERSITAT ZURICH
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
191K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Cell-to-cell heterogeneity in biological systems has been broadly studied in unicellular organisms and mammals. Furthermore, non-genetic, in addition to genetic heterogeneity has been recently proposed to support tumour growth and to induce resistance to cancer therapy. However, the molecular events on a spatial and temporal level that lead to the emergence of tumour heterogeneity are largely unknown. To address this question, I will study breast cancer, which shows the highest cancer incidence in women and is characterised by extensive intra- and inter-patient heterogeneity in cellular and molecular phenotypes. As model system, I select 3D organoid cultures, which are gaining popularity in cancer research due to their ability to reconstruct tumour-like molecular features and to recapitulate treatment response.
Here, I propose experimental and computational time-course analyses of breast cancer organoids to understand molecular and spatial determinants that underlie the emergence of heterogeneity in cancer cell phenotypes. On the experimental side, I will use imaging mass cytometry and perturbation experiments to capture and validate spatio-temporal changes in cellular phenotypes, interactions and signalling networks. Statistical modelling will quantify dynamic changes in phenotypic heterogeneity over the time-course of organoid growth. Finally, I will predict the emergence of intra-organoid heterogeneity across multiple organoid lines, which allows me to derive targeted treatment strategies.
In sum, the proposed work will disentangle and perturb the spatio-temporal emergence of phenotypic intra-tumour heterogeneity, which is characteristic of breast cancer tissues.